RecallDepth
Class II Ongoing

Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-904 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6007-61

Company
The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories
Recall Initiated
January 21, 2025
Posted
February 26, 2025
Recall Number
D-0226-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
82,281 cartons
Firm Location
La Vergne, TN, United States

Reason for Recall

Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.

Distribution

Nationwide U.S. and Puerto rico

Lot / Code Info

Lot #s: N01424, N01425, Exp 03/31/2025; N01659, N01660, Exp 08/31/2025; N01668, 09/2025; N01679, N01704, N01745, Exp 10/31/2025; N01856, Exp 02/28/2026; N01973, Exp 05/31/2026; N02079, Exp 08/31/2026.

More recalls by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories

View all recalls by this company →

Other recent Class II Drug recalls